Call for Abstract

Scientific Program

7th International Conference on Drug Discovery and Toxicology, will be organized around the theme “New Era Technologies in Drug Formulation & Novelties in Toxicology”

Drug Discovery Congress 2020 is comprised of 20 tracks and 100 sessions designed to offer comprehensive sessions that address current issues in Drug Discovery Congress 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Public Health Toxicology

  • Track 1-1Hepato and renal toxicology
  • Track 1-2Reproductive and developmental toxicology
  • Track 1-3Immunotoxicology
  • Track 1-4Metal toxicology
  • Track 1-5Bone marrow toxicity
  • Track 1-6Neurotoxicology
  • Track 1-7Nanoparticle toxicology

Track 2:Future Advancements in Drug Discovery

  • Track 2-1Phenotypic drug discovery
  • Track 2-2High throughput screening by mass spectroscopy
  • Track 2-3Current trends in label free technologies
  • Track 2-4Next generation sequencing technologies

Track 3:Pharmaceutical Packing and Labeling

  • Track 3-1Design for a safer dispensing process
  • Track 3-2 Microelectronics and electronic packaging
  • Track 3-3Automated Packaging Machine

Track 4:Bioavailability and Bioequivalence in Drug Development

  • Track 4-1Pharmacokinetics in relative bioavalibility
  • Track 4-2 Absolute oral bioavailability and disposition kinetics 
  • Track 4-3Theoretical Analysis of Drug Dissolution
  • Track 4-4Various Approaches to Enhance Drug Solubility

Track 5: Pharmaceutical Engineering

  • Track 5-1Beginning of mass production
  • Track 5-2Biomaterials and Biomechanics
  • Track 5-3Automation in Pharmaceutical Manufacturing

Track 6:New Trends in Pharmaceutical Formulation Development

  • Track 6-1Topical Cream-Based Dosage Forms
  • Track 6-2Developments in injectable drug delivery
  • Track 6-3new oral drug delivery -mouth dissolving formulation
  • Track 6-4Design and formulation of capsules
  • Track 6-5Targeted delivery of respiratory vaccines

Track 7:Research and Advancements Pharmaceutical Industry

  • Track 7-1Targeting RNA with small molecules
  • Track 7-2Role of artificial intelligence in drug discovery
  • Track 7-3Bioprinting
  • Track 7-4Human organs-on-a-chip

Track 8: Post Marketing Surveillance

  • Track 8-1Monitoring techniques
  • Track 8-2Regulatory affairs
  • Track 8-3Pharmacovilance
  • Track 8-4Drug regulation

Track 9: Computer Aided Drug Designing

  • Track 9-1Structure and ligand based drug design
  • Track 9-2Protein Binding site identification
  • Track 9-3Lead optimization in drug metabolism

Track 10:Risk Assessment and Risk Management

  • Track 10-1Identify toxic hazards
  • Track 10-2Dose response evaluation
  • Track 10-3Exposure assessment
  • Track 10-4Risk characterization

Track 11:Drug Discovery and Development

  • Track 11-1Traditional medicines and herbal therapy
  • Track 11-2Natural products in drug discovery
  • Track 11-3Lead identification and validation
  • Track 11-4Quantitative structure activity relationship
  • Track 11-5Development challenges

Track 12:Toxicology

  • Track 12-1Clinical and medicinal toxicology
  • Track 12-2Forensic toxicology
  • Track 12-3Food and nutritional toxicology
  • Track 12-4Analytical toxicology
  • Track 12-5Environmental toxicology

Track 13: Novel Drug Delivery System

  • Track 13-1Drug delivery system
  • Track 13-2Microencapsulation
  • Track 13-3Nasal and Pulmonary routes of administration
  • Track 13-4Novel drug targets

Track 14: Bio-markers and Proteomics in Drug Discovery

  • Track 14-1Mechanism of action of drugs
  • Track 14-2Molecular imaging of drug
  • Track 14-3Monitoring patient health
  • Track 14-4Diagnosis of disease condition

Track 15: Quality Assurance and Quality Control

  • Track 15-1Good manufacturing practice (GMP)
  • Track 15-2Product safety testing
  • Track 15-3Quality control in production process
  • Track 15-4Pharmaceutical drug validation

Track 16: Molecular Modeling In Drug Designing

  • Track 16-1Generation of Chemical Structures
  • Track 16-2Multiscale Molecular Structure
  • Track 16-3Molecular Docking
  • Track 16-4Pharmachophore modelling

Track 17: Bioinformatics and Pharmocogenomics in Drug Discovery

  • Track 17-1Personalized medication
  • Track 17-2Revive orphan drug
  • Track 17-3 Target identification in drug discovery

Track 18:Novel Techniques in Chromatography

  • Track 18-1Electrospray Ionization Mass Spectroscopy.
  • Track 18-2Hydrophobic Interaction chromatography.
  • Track 18-3Paper Chromatography Hybridization Assay (PACHA)
  • Track 18-4Convergence Chromatography.
  • Track 18-5High-performance and Immuno-affinity chromatography.
  • Track 18-6Optical force chromatography.

Track 19:Role of Nanotechnology in Drug Discovery

  • Track 19-1Nanomedicine
  • Track 19-2Pharmaceutical Nanotechnology
  • Track 19-3Nano drugs, Nanomaterial & Biopharmaceuticals
  • Track 19-4Dendrimers
  • Track 19-5Polymeric and ceramic nano particles
  • Track 19-6Development of nanoemulsions
  • Track 19-7Micelles for drug targeting
  • Track 19-8Nano-biotechnology in drug discovery

Track 20:Pre-Clinical and Clinical Research

  • Track 20-1Management of equipment
  • Track 20-2Importance of species selection
  • Track 20-3Ethical issues
  • Track 20-4Phases in clinical trails